Professional Documents
Culture Documents
dS
= B ( + )S (t )
dt
dA
= S ( t ) ( 1 + ) A (t )
dt
dC
= 1 A ( t ) ( 2 + )C (t )
dt
dR
= (1 ) 1 A ( t ) + 2 C ( t ) R ( t )
dt
METHODOLOGY
Designing the Model (Stages of disease, HCV): A
compartmental model is used to represent the
dynamics of infection for HCV as shown in Figure M1
below. In the figure, the population is subdivided into
a number of subsets according to the most important
stages of HCV. In this model, four subsets are of
interest: we denote the number of susceptibles by S,
the number of acutely infected individuals by A, the
number of chronic carriers by C and the number
recovered by R. The individuals are recruited into the
susceptible class by the quantity B, and the mortality
rate (naturally) given as . The susceptible hosts are
infected by the acute infection class with a force of
infection , which depends on the rate of borrowing
injecting equipment k, and the transmission rates
(probabilities ba, bc) [2].
Sus
Chr
(1.0)
(t) = k (b
N (t)
+ b
N (t)
Acu
ds
dt
da
dt
dc
dt
dr
dt
Rec
(kb
= B
=
(kb
a ( t ) + kb
a ( t ) + kb
a (t )
= (1 )
c ( t ) )s (t
c ( t ) )s (t
+
a (t ) +
) s (t )
) (
(1.2)
)a (t )
)c (t )
c (t ) r (t )
42
ds
dt
da
dt
dc
dt
dr
dt
= (1 p ) ( (t ) + ) s (t )
RESULTS
= (t ) s (t ) ( 1 + )a (t )
(2.0)
= 1 a (t ) ( 2 + )c (t )
= (1 ) 1 a (t ) + p + 2 c (t ) r (t )
a (t ) = A(t ) = Na (t )
c (t ) = C (t ) = Nc(t )
(t ) = a (t ) = c (t )
(2.1)
d a (t )
dA(t )
da (t )
=
= N
dt
dt
dt
(2.2)
d c (t )
dC (t )
dc(t )
=
= N
dt
dt
dt
We formulated the second, third equations in (2.0) in
terms of the force of infection given in (2.2) to obtain
this equation:
ds
= (1 p ) ( (t ) + ) s (t )
dt
d a
= ( 1 + )a (t )[ Ro s (t ) 1]
dt
dc
= 1 a (t ) ( 2 + )c(t )
dt
(2.3)
Where
R0 =
N
1 +
(2.4)
43
1.0
Transmission of HCV,k=20
1.0
Transmission of HCV,k=10
0.6
0.8
Susceptible
Acute
Chronic
Removed
0.0
0.2
0.4
Population
0.0
0.2
0.4
Population
0.6
0.8
Susceptible
Acute
Chronic
Removed
20
40
60
80
100
120
Duration of Exposure(months)
20
40
60
80
100
k=20
Studying the impact of vaccination: Let us first
consider the case of no vaccination (p=0). As an
example we take a modest R0=10, 1= 5yr-1,
2=0.01yr-1 in a population with birth and death rate
=1/70yr-1. The infection is introduced with an initial
seed corresponding to 0.0001 yr-1. The time window
considered is in years.
1.0
k=10
The duration-dependent force of infection was
estimated by the model at different contact rates k.
The Figure 2 below shows the estimated forces of
infections at different values of the frequency of
sharing injecting materials, k.
0.6
0.4
0.0
0.2
Force of infection
0.8
FOI(5)
FOI(10)
FOI(15)
FOI(20)
FOI(25)
20
40
60
80
120
Duration of Exposure(months)
100
120
Duration of Exposure(months)
44
45
DISCUSSION
The mathematical models fitted were presented by
(Kretzschmar and Wiessing, 2006). We assumed a
homogenous population of IDUs for the transmission of
HCV. The results show that early drug users may have
a high risk of being infected with HCV based on the
frequency of borrowing injecting materials or rates of
contacts. The force of infection for the population
varying rates of borrowing injecting materials i.e. k=1,
5,,25 also indicated that for shorter duration of
exposure, the force of infection was high.
We have also introduced a mathematical model that
looks at vaccination program for the Susceptible, Acute
infection and Chronic carriers. We observed that early
vaccination program with higher coverage of the
population reduces the force of infection thus reducing
the rates at which individuals become infected. This
helps in the slow growth of new infections, thus reducing
epidemic cycles.
REFERENCES
Alter, H.J., Seeff, L. B. (2000). Recovery, persistence, and
sequelae in hepatitis C virus infection: a perspective
on long-term outcome. Seminars in Liver Disease 20:
17-35.
Clemens, J.M., Taskar, S., Chau, K., Vallari, D., Shih, J.
W., Alter, H.J., Schleicher, J. B., Mimms, L.T.(1992),
Lgm antibody response in acute hepatitis C viral
infection Blood 79: 169-72
Di Bisceglie, A.M. (1998), Hepatitis C. The Lancet
352:351-5
Diamond ID, McDonald JM. Analysis of current status
data. In: Trussel J, Hankinson, Tiltan J, eds.
Demographic Application of Event History Analysis.
Oxford: Oxford University Press, 1992.
Farrington CP. Modeling forces of infection for measles,
mumps and rubella. Statistics in Medicine 1990; 9:953
967.
Keiding N. Age-specific incidence and prevalence: a
statistical perspective. J R Statist Soc A 1991; 154(3):
371412.
Kretzschmar M, Wiessing L (2006): Modelling the
transmission of hepatitis C in injecting drug users. In
Hepatitis C and injecting drug use: impact, costs and
policy options Edited by: European Monitoring Centre
for Drugs and Drug Addiction; 2006:143-159.
Mathei C, Shkedy Z, Denis B, Kabali C, Aerts M,
Molenberghs G, Van Damme P and Buntinx F (2005).
Evidence for a substantial role of sharing of injecting
paraphernalia other than syringes/needles to the
spread of hepatitis C among injecting drug users.
Journal of Viral Hepatitis, 2006, 13, 560570
Shkedy, Z. and Van Effelterre, T. Modelling infectious
diseases. Course notes. University of Hasselt , 2007.
46